FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

4511411000001108: Razoxane 125mg tablets (Cambridge Laboratories) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17785301000001112 Razoxane 125mg tablets (Cambridge Laboratories) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
41473801000001115 Razoxane 125mg tablets (Cambridge Laboratories Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Razoxane 125mg tablets (Cambridge Laboratories) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) Is a Product containing precisely razoxane 125 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) Has active ingredient Cytoprotective agent false Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) Has active ingredient Substance with chelating agent mechanism of action false Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) Has active ingredient Antidote false Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) Has active ingredient Razoxane false Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) Has specific active ingredient Razoxane true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Razoxane 125mg tablets (Cambridge Laboratories) 30 tablet Is pack of False Razoxane 125mg tablets (Cambridge Laboratories) Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) 30 tablet Has AMP True Razoxane 125mg tablets (Cambridge Laboratories) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start